MedPath

Effect of tolvaptan in decompensated liver cirrhosis patients

Not Applicable
Conditions
decompensated liver cirrhosis patients
Registration Number
JPRN-UMIN000016188
Lead Sponsor
shonan kamakura general hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

(1)The anuric patients (2)Patients with urinary retention (3) hypernatremia (4)Patients with poorly controlled hepatocellular carcinoma and hepatic encephalopathy were exclude

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath